|[September 10, 2013]
Research and Markets: Endometriosis - Pipeline Review, H2 2013
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/cnhl7n/endometriosis)
has announced the addition of the "Endometriosis
- Pipeline Review, H2 2013" report to their offering.
'Endometriosis - Pipeline Review, H2 2013', provides an overview of the
indication's therapeutic pipeline. This report provides information on
the therapeutic development for Endometriosis, complete with latest
updates, and special features on late-stage and discontinued projects.
It also reviews key players involved in the therapeutic development for
- A snapshot of the global therapeutic scenario for Endometriosis.
- A review of the Endometriosis products undr development by companies
and universities/research institutes based on information derived from
company and industry-specific sources.
- Coverage of products based on various stages of development ranging
from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and
- Coverage of the Endometriosis pipeline on the basis of route of
administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
Takeda Pharmaceutical Company Limited
Neurocrine Biosciences, Inc.
Astellas Pharma Inc.
Kissei Pharmaceutical Co., Ltd.
Repros Therapeutics Inc.
DONGKOOK Pharmaceutical Co., Ltd.
Lipicard Technologies Limited
Orphagen Pharmaceuticals, Inc.
Quatrx Pharmaceutical Company
For more information visit http://www.researchandmarkets.com/research/cnhl7n/endometriosis.
About Research and Markets
Research and Markets is the world's leading source for international
market research reports and market data. We provide you with the latest
data on international and regional markets, key industries, the top
companies, new products and the latest trends.
[ Back To Technology News's Homepage ]